{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:12:46Z","timestamp":1786990366755,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ihj.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T18:57:21Z","timestamp":1737658641000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clonal hematopoiesis of indeterminate potential and cardiovascular diseases: A review"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-596X","authenticated-orcid":false,"given":"Nagendra Boopathy","family":"Senguttuvan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodhini","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralidharan","family":"TR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Sankaranarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2827-8680","authenticated-orcid":false,"given":"Vettriselvi","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanikachalam","family":"Sadagopan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ihj.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ihj.2025.01.006_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1016\/j.ihj.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.leukres.2007.03.015","article-title":"Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface","volume":"31","author":"Wimazal","year":"2007","journal-title":"Leuk Res"},{"issue":"21","key":"10.1016\/j.ihj.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1182\/blood-2015-08-663237","article-title":"Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression","volume":"126","author":"Cargo","year":"2015","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ihj.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ihj.2025.01.006_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.ihj.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ihj.2025.01.006_bib8","first-page":"1401","article-title":"Clonal hematopoiesis and atherosclerosis","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ihj.2025.01.006_bib9","doi-asserted-by":"crossref","DOI":"10.1182\/hem.V14.5.7618","article-title":"CHIP and coronary heart disease: clonal hematopoiesis increases atherosclerosis","volume":"14","author":"Roberts","year":"2017","journal-title":"The Hematologist"},{"issue":"26","key":"10.1016\/j.ihj.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ihj.2025.01.006_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jamaoncol.2018.2297","article-title":"Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors","volume":"4","author":"Ptashkin","year":"2018","journal-title":"JAMA Oncol"},{"issue":"25","key":"10.1016\/j.ihj.2025.01.006_bib12","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ihj.2025.01.006_bib13","doi-asserted-by":"crossref","first-page":"e1339","DOI":"10.1016\/S2214-109X(18)30407-8","article-title":"The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016","volume":"6","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ihj.2025.01.006_bib14","unstructured":"Anon. GBD Compare. Institute for Health Metrics and Evaluation Accessed April 14, 2024. http:\/\/[vizhub.healthdata.org\/gbd-compare]."},{"key":"10.1016\/j.ihj.2025.01.006_bib15","unstructured":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study - PubMed [Internet]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15364185\/."},{"issue":"4","key":"10.1016\/j.ihj.2025.01.006_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.ihj.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ihj.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2020.00088","article-title":"The evolving understanding and approach to residual cardiovascular risk management","volume":"7","author":"Dhindsa","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.ihj.2025.01.006_bib20","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ihj.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2019.05.045","article-title":"Clonal hematopoiesis of indeterminate potential reshapes age-related CVD: JACC review topic of the week","volume":"74","author":"Khetarpal","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ihj.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ihj.2025.01.006_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/ATVBAHA.122.318928","article-title":"Clonal hematopoiesis of indeterminate potential is associated with coronary microvascular dysfunction in early nonobstructive coronary artery disease","volume":"43","author":"Akhiyat","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.ihj.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.recesp.2021.05.007","article-title":"Prevalence and characteristics of clonal hematopoiesis in heart failure","volume":"74","author":"Palomo","year":"2021","journal-title":"Rev Esp Cardiol"},{"issue":"10","key":"10.1016\/j.ihj.2025.01.006_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","article-title":"Patients with heart failure have an increased risk of incident cancer","volume":"62","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ihj.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamacardio.2020.2468","article-title":"Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with severe degenerative aortic valve stenosis or chronic postischemic heart failure","volume":"5","author":"Abplanalp","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"suppl ment_2","key":"10.1016\/j.ihj.2025.01.006_bib27","article-title":"DNMT3A clonal hematopoiesis-driver mutations are associated with profound changes in monocyte and T cell signatures in humans with heart failure","volume":"41","author":"Abplanalp","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ihj.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","article-title":"Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations","volume":"42","author":"Assmus","year":"2021","journal-title":"Eur Heart J"},{"issue":"suppl ment_2","key":"10.1016\/j.ihj.2025.01.006_bib29","article-title":"Somatic blood cell mutations at low variant allele frequency in distinct risk genes are associated with increased mortality in patients with chronic ischemic heart failure","volume":"41","author":"Kiefer","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ihj.2025.01.006_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53244","article-title":"Clonal hematopoiesis and incident heart failure with preserved ejection fraction","volume":"7","author":"Schuermans","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.ihj.2025.01.006_bib31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","article-title":"Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation","volume":"41","author":"Mas-Peiro","year":"2020","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ihj.2025.01.006_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ajt.2023.02.017","article-title":"Clonal hematopoiesis and cardiac transplantation: the intersection of inflammation and arteriopathy?","volume":"23","author":"Bhattacharya","year":"2023","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ihj.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/ajt.17172","article-title":"Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients","volume":"22","author":"Scolari","year":"2022","journal-title":"Am J Transplant"},{"issue":"18","key":"10.1016\/j.ihj.2025.01.006_bib34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.123.065597","article-title":"Clonal hematopoiesis of indeterminate potential with loss of Tet2 enhances risk for atrial fibrillation through Nlrp3 inflammasome activation","volume":"149","author":"Lin","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ihj.2025.01.006_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurheartj\/ehad670","article-title":"Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias","volume":"45","author":"Schuermans","year":"2024","journal-title":"Eur Heart J [Internet]"},{"issue":"3","key":"10.1016\/j.ihj.2025.01.006_bib36","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","article-title":"Clonal hematopoiesis is associated with higher risk of stroke","volume":"53","author":"Bhattacharya","year":"2022","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.ihj.2025.01.006_bib37","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1093\/rheumatology\/keac108","article-title":"Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)","volume":"61","author":"David","year":"2022","journal-title":"Rheumatology (Oxford) [Internet]"},{"issue":"1","key":"10.1016\/j.ihj.2025.01.006_bib38","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-022-33093-3","article-title":"Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease","volume":"13","author":"Uddin","year":"2022","journal-title":"Nat Commun [Internet]"},{"issue":"1","key":"10.1016\/j.ihj.2025.01.006_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41598-021-04308-2","article-title":"Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV","volume":"12","author":"Bick","year":"2022","journal-title":"Sci Rep"},{"issue":"6327","key":"10.1016\/j.ihj.2025.01.006_bib40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ihj.2025.01.006_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ihj.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease","volume":"122","author":"Fuster","year":"2018","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.ihj.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/bloodadvances.2019000770","article-title":"High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential","volume":"4","author":"Busque","year":"2020","journal-title":"Blood Adv"},{"issue":"436","key":"10.1016\/j.ihj.2025.01.006_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.ihj.2025.01.006_bib45","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation","volume":"128","author":"Edelmann","year":"2018","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.ihj.2025.01.006_bib46","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","article-title":"Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 V617F mice","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"issue":"7939","key":"10.1016\/j.ihj.2025.01.006_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","article-title":"Common and rare variant associations with clonal haematopoiesis phenotypes","volume":"612","author":"Kessler","year":"2022","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.ihj.2025.01.006_bib48","first-page":"1623","article-title":"What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics","volume":"136","author":"Steensma","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ihj.2025.01.006_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12979-022-00278-9","article-title":"Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics","volume":"19","author":"Uddin","year":"2022","journal-title":"Immun Ageing"},{"issue":"24","key":"10.1016\/j.ihj.2025.01.006_bib50","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1182\/bloodadvances.2022008376","article-title":"Patient perspectives on testing for clonal hematopoiesis of indeterminate potential","volume":"6","author":"Sella","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ihj.2025.01.006_bib51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.ihj.2025.01.006_bib52","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ihj.2025.01.006_bib53","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2025.01.006_bib54","unstructured":"https:\/\/forpatients.roche.com\/en\/trials\/cardiovascular-disorder\/coronary-artery-disease\/a-phase-ic-multicenter--randomized--double-blind--placebo-contro.html."},{"issue":"43","key":"10.1016\/j.ihj.2025.01.006_bib55","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1093\/eurheartj\/ehae546","article-title":"Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis","volume":"45","author":"Zuriaga","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ihj.2025.01.006_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molmed.2016.12.007","article-title":"Inflammasome priming in sterile inflammatory disease","volume":"23","author":"Patel","year":"2017","journal-title":"Trends Mol Med"},{"issue":"13","key":"10.1016\/j.ihj.2025.01.006_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7761","key":"10.1016\/j.ihj.2025.01.006_bib58","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ihj.2025.01.006_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/bj20030304","article-title":"The PAAD\/PYRIN-only protein POP1\/ASC2 is a modulator of ASC-mediated nuclear-factor-kappaB and pro-caspase-1 regulation","volume":"373","author":"Stehlik","year":"2003","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.ihj.2025.01.006_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jmb.2017.10.004","article-title":"COPs and POPs patrol inflammasome activation","volume":"430","author":"Indramohan","year":"2018","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.ihj.2025.01.006_bib61","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","article-title":"NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma","volume":"108","author":"McKee","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.ihj.2025.01.006_bib62","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40744-021-00304-0","article-title":"Effect of tocilizumab on LDL and HDL characteristics in patients with rheumatoid arthritis. An observational study","volume":"8","author":"Pierini","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"6","key":"10.1016\/j.ihj.2025.01.006_bib63","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.ihj.2025.01.006_bib64","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ihj.2025.01.006_bib65","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2025.01.006_bib66","series-title":"ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People with a Heart Attack (ARTEMIS)","year":"2024"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483225000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483225000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T14:27:45Z","timestamp":1742567265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483225000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0019483225000070"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2025.01.006","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal hematopoiesis of indeterminate potential and cardiovascular diseases: A review","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}